RecruitingNCT07215611

Financial Toxicity in Patients With Resected Soft Tissue and Bone Sarcomas

Sponsor

M.D. Anderson Cancer Center

Enrollment

100 participants

Start Date

Sep 2, 2025

Study Type

OBSERVATIONAL

Conditions

Financial Toxicity Bone Sarcomas

Summary

To learn about the financial stress patients undergoing surgery to treat orthopedic cancer experience because of the costs of cancer care, and to learn about the effects of financial stress on participants quality of life.

Eligibility

Plain Language Summary

Simplified for easier understanding

This study is collecting information about financial stress and burden (called financial toxicity) in patients with bone or soft tissue sarcoma who are undergoing surgery. The goal is to better understand the financial impact of these cancers on patients. **You may be eligible if...** - You are an adult patient being seen before surgery for a primary malignant bone tumor or soft tissue sarcoma - You are receiving care at the study institution - You can read and write in English **You may NOT be eligible if...** - You cannot read or write in English Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.